ACELLUVAX, created in 2002 (Italy), from 2951 sister brands and 17477 competing brands. ACELLUVAX is a brand of NOVARTIS N, listed on the stock exchange of Zurich. The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. ACELLUVAX is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(ACELLUVAX)
over 5 years*
CHF 103.21